edelfosine has been researched along with Cancer of Lung in 8 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lung cancer is the most prevalent cancer and a high fatality disease." | 1.48 | Edelfosine: An Antitumor Drug Prototype. ( Barbuto, JAM; Costa, CJS; de Azevedo, RA; Ferreira, AK; Ferro, ES; Jorge, SD; Mambelli, LI; Pettinati, TN; Ramos, RN; Rodrigues, CP; Teixeira, SF, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teixeira, SF | 1 |
| Rodrigues, CP | 1 |
| Costa, CJS | 1 |
| Pettinati, TN | 1 |
| de Azevedo, RA | 1 |
| Mambelli, LI | 1 |
| Jorge, SD | 1 |
| Ramos, RN | 1 |
| Ferro, ES | 1 |
| Barbuto, JAM | 1 |
| Ferreira, AK | 1 |
| González-Fernández, Y | 1 |
| Brown, HK | 1 |
| Patiño-García, A | 1 |
| Heymann, D | 1 |
| Blanco-Prieto, MJ | 1 |
| Shafer, SH | 2 |
| Williams, CL | 2 |
| Berdel, WE | 2 |
| Bausert, WR | 1 |
| Weltzien, HU | 1 |
| Modolell, ML | 1 |
| Widmann, KH | 1 |
| Munder, PG | 1 |
| Marino-Albernas, JR | 1 |
| Bittman, R | 1 |
| Peters, A | 1 |
| Mayhew, E | 1 |
| Strassheim, D | 1 |
| Phelps, SH | 1 |
| Lu, X | 1 |
| Arthur, G | 1 |
| Storme, GA | 1 |
| van Blitterswijk, WJ | 1 |
| Bruyneel, EA | 1 |
| De Bruyne, GK | 1 |
| Mareel, MM | 1 |
8 other studies available for edelfosine and Cancer of Lung
| Article | Year |
|---|---|
Edelfosine: An Antitumor Drug Prototype.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Re | 2018 |
Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell | 2018 |
Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Cycle; | 2003 |
The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma.
Topics: Animals; Female; Lung Neoplasms; Lysophosphatidylcholines; Macrophages; Mice; Mice, Inbred C57BL; Ne | 1980 |
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Female; Glycosides; Huma | 1996 |
Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Topics: Antineoplastic Agents; Calcium; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Resistan | 2000 |
The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Topics: Acylation; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Fatty Acids; Humans; | 1992 |
Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
Topics: Animals; Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Chickens; Drug Ev | 1985 |